查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1673062

生殖器疣治療市場按藥物類型、給藥途徑、分銷管道和地區分類

Genital Warts Treatment Market, By Drug Type, By Route of Administration, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 149 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球生殖器疣治療市場規模估計為 20.1 億美元，預計 2032 年將達到 29.1 億美元，2025 年至 2032 年的複合年成長率為 5.4%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 20.1億美元
效能資料 2020-2024 預測期 2025-2032
預測期：2025 年至 2032 年複合年成長率 5.40% 2032 年金額預測 29.1億美元
數字。 2025 年生殖器疣治療市場佔有率（%），依地區分類
生殖器疣治療市場-IMG1

全球生殖器疣治療市場的成長是由世界各地人類乳突病毒 (HPV) 感染的日益流行所推動的。生殖器疣，也稱為生殖器尖形濕疣，是出現在生殖器或肛門區域的皮膚生長物，由某些類型的 HPV 引起。根據聯合國世界衛生組織（WHO）統計，約90%的生殖器HPV感染疾病是無症狀的，並且會自然消退。然而，持續的HPV感染可能導致生殖器疣，需要臨床治療。人們對安全性行為的認知不斷提高以及有效治療方案的可用性導致尋求治療生殖器疣的患者增加，從而推動了市場成長。

市場動態

全球生殖器疣治療市場的成長得益於危險性行為導致的 HPV 感染發病率不斷上升、人們對生殖器疣及其治療認知的不斷提高、人們對性健康的興趣日益濃厚以及動態療法等新治療方法的迅速普及。然而，與性傳染病（包括生殖器疣）相關的社會恥辱、新興市場缺乏認知以及新治療方案的高成本可能會阻礙市場成長。持續尋找更安全、更有效的治療方法和疫苗可能會為患者和市場參與企業帶來雙贏的機會。

研究的主要特點

本報告對全球生殖器疣治療市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設 2024 年為基準年。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球生殖器疣治療市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數列出的。

研究涉及的主要企業包括默克公司、Synermore BIoTech、Verrica Pharmaceuticals、Theravectys、Qiagen、Immuno bIoTech 等。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球生殖器疣治療市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。

相關人員可以透過全球生殖器疣治療市場分析中使用的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 監管情景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第 4 章。全球生殖器疣治療市場-冠狀病毒 (COVID-19) 大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 2020 年至 2032 年全球生殖器疣治療市場（按藥物類型分類）（十億美元）

  • 介紹
  • 咪喹莫特
  • Podophyllin與鬼臼毒素
  • 三氯乙酸
  • 兒茶素
  • 其他

6. 2020 年至 2032 年全球生殖器疣治療市場（依給藥途徑分類）（十億美元）

  • 介紹
  • 腸外
  • 局部的

7. 2020-2032 年全球生殖器疣治療市場按通路分類（十億美元）

  • 介紹
  • 醫院藥房
  • 零售藥局
  • 網路藥局

8. 2020 年至 2032 年全球生殖器疣治療市場（按地區分類）（十億美元）

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 公司簡介
    • Merck &Co., Inc.
    • Perrigo Company PLC
    • 3M Company
    • Bausch Health
    • Taro Pharmaceutical Industries
    • Novan Inc.
    • Serum Institute of India Pvt. Ltd.
    • Orgenesis bIoTech company
    • Verrica Pharmaceuticals
    • Sanofi SA
    • AbbVie Inc.
    • Lee's Pharmaceutical Holdings Ltd
    • Cassiopea
    • Glenmark Pharmaceuticals
    • Novartis International AG

第 10 章分析師建議

  • 興衰
  • 一致的機會地圖

第 11 章 章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4534

Global Genital Warts Treatment Market is estimated to be valued at USD 2.01 Bn in 2025 and is expected to reach USD 2.91 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.01 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.40% 2032 Value Projection: USD 2.91 Bn
Figure. Genital Warts Treatment Market Share (%), By Region 2025
Genital Warts Treatment Market - IMG1

Global genital warts treatment market growth is driven by rising prevalence of human papillomavirus (HPV) infections worldwide. Genital warts, also known as condyloma acuminata, are skin growths that appear in the genital and anal areas, and are caused by certain types of HPV. According to the UN World Health Organization (WHO), about 90% of genital HPV infections are asymptomatic and clear up on their own. However, persistent HPV infections can lead to genital warts that require clinical treatment. Increasing awareness about safer sex practices and availability of effective treatment options have prompted more patients to seek medical help for genital warts, thus, driving the market growth.

Market Dynamics:

Global genital warts treatment market growth is driven by growing incidence of HPV infections due to risky sexual behaviors, increasing awareness about genital warts and their treatment, growing focus on sexual wellness, and rapid adoption of newer treatment modalities like photodynamic therapy. However, social stigma associated with STDs including genital warts, lack of awareness in developing nations, and high cost of newer treatment options can hamper the market growth. Ongoing research into safer and more effective therapeutic drugs and vaccines can offer lucrative opportunities for both patients and market players.

Key Features of the Study:

This report provides in-depth analysis of the global genital warts treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global genital warts treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck & Co., Synermore Biotech, Verrica Pharmaceuticals, Theravectys, Qiagen, Immuno biotech

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global genital warts treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genital warts treatment market

Detailed Segmentation-

  • By Drug Type
    • Imiquimod
    • Podophyllin and Podofilox
    • Trichloroacetic Acid
    • Sinecatechins
    • Others
  • By Route of Administration
    • Parenteral
    • Topical
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Merck & Co., Inc.
    • Perrigo Company PLC
    • 3M Company
    • Bausch Health
    • Taro Pharmaceutical Industries
    • Novan Inc.
    • Serum Institute of India Pvt. Ltd.
    • Orgenesis biotech company
    • Verrica Pharmaceuticals
    • Sanofi S.A.
    • AbbVie Inc.
    • Lee's Pharmaceutical Holdings Ltd
    • Cassiopea
    • Glenmark Pharmaceuticals
    • Novartis International AG

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Genital Warts Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Genital Warts Treatment Market, By Drug Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Imiquimod
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Podophyllin and Podofilox
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Trichloroacetic Acid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sinecatechins
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Genital Warts Treatment Market, By Route of Administration, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Parenteral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Topical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Genital Warts Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Genital Warts Treatment Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Perrigo Company PLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • 3M Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bausch Health
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Taro Pharmaceutical Industries
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novan Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Serum Institute of India Pvt. Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Orgenesis biotech company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Verrica Pharmaceuticals
    • Sanofi S.A.
    • AbbVie Inc.
    • Lee's Pharmaceutical Holdings Ltd
    • Cassiopea
    • Glenmark Pharmaceuticals
    • Novartis International AG

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact